Oncoinvent Announces Positive Final Data from Phase 1/ 2a Trial of Radspherin® in Patients with Colorectal Peritoneal Metastases

Oncoinvent AS Norway

View original content:https://www.prnewswire.co.uk/news-releases/oncoinvent-announces-positive-final-data-from-phase-12a-trial-of-radspherin-in-patients-with-colorectal-peritoneal-metastases-302484875.html